Gomekli 2 mg/1
mirdametinib · CAPSULE · SpringWorks Therapeutics, Inc.
No Recall History
Plain English
Gomekli is a capsule containing mirdametinib at 2 mg/1, taken oral. Manufactured by SpringWorks Therapeutics, Inc..
Key Facts
- Brand Name
- Gomekli
- Generic Name
- mirdametinib
- NDC Code (Product)
82448-260- Manufacturer
- SpringWorks Therapeutics, Inc.
- Strength
- 2 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA219389
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 02/11/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Gomekli used for?
Gomekli contains mirdametinib. It is a capsule taken oral. Consult your doctor for specific uses.
Is Gomekli a controlled substance?
Gomekli is not classified as a controlled substance by the DEA.
What is the generic name for Gomekli?
The generic name for Gomekli is mirdametinib. There are no other listed brand versions of mirdametinib.
What is the NDC code for Gomekli 2 mg/1?
The NDC (National Drug Code) for Gomekli 2 mg/1 is 82448-260, listed by SpringWorks Therapeutics, Inc..
Other Gomekli Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)